Jiesi Luo

2.4k total citations
51 papers, 1.4k citations indexed

About

Jiesi Luo is a scholar working on Molecular Biology, Surgery and Biomaterials. According to data from OpenAlex, Jiesi Luo has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Surgery and 11 papers in Biomaterials. Recurrent topics in Jiesi Luo's work include Tissue Engineering and Regenerative Medicine (14 papers), Pluripotent Stem Cells Research (11 papers) and Electrospun Nanofibers in Biomedical Applications (11 papers). Jiesi Luo is often cited by papers focused on Tissue Engineering and Regenerative Medicine (14 papers), Pluripotent Stem Cells Research (11 papers) and Electrospun Nanofibers in Biomedical Applications (11 papers). Jiesi Luo collaborates with scholars based in China, United States and Canada. Jiesi Luo's co-authors include Zhaoxue Yin, Xiaoming Shi, Yibing Qyang, Yuebin Lv, Biraja C. Dash, Jiaonan Wang, Xiang Gao, Alan Dardik, Huashuai Chen and Pengfei Zhu and has published in prestigious journals such as The Journal of Experimental Medicine, Biomaterials and Scientific Reports.

In The Last Decade

Jiesi Luo

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiesi Luo China 20 394 322 248 213 188 51 1.4k
Jinxi Wang China 28 1.0k 2.6× 524 1.6× 212 0.9× 167 0.8× 268 1.4× 119 2.7k
Guihua Liu China 25 727 1.8× 1.0k 3.3× 151 0.6× 314 1.5× 201 1.1× 83 2.1k
Manabu Akahane Japan 28 305 0.8× 960 3.0× 123 0.5× 132 0.6× 782 4.2× 143 2.9k
Amanda J. LeBlanc United States 19 275 0.7× 246 0.8× 131 0.5× 85 0.4× 105 0.6× 57 1.0k
Maelene L. Wong United States 15 407 1.0× 578 1.8× 88 0.4× 383 1.8× 147 0.8× 20 1.4k
Masayuki Kubo Japan 20 356 0.9× 243 0.8× 131 0.5× 95 0.4× 63 0.3× 67 1.2k
Manuel González Ecuador 16 345 0.9× 399 1.2× 730 2.9× 67 0.3× 49 0.3× 57 2.4k
H. Wayne Sampson United States 23 381 1.0× 372 1.2× 87 0.4× 67 0.3× 206 1.1× 71 1.6k
Stephen R. Kearns Ireland 23 142 0.4× 810 2.5× 64 0.3× 104 0.5× 168 0.9× 89 1.6k
Loren E. Wold United States 25 357 0.9× 294 0.9× 1.1k 4.3× 160 0.8× 81 0.4× 48 2.2k

Countries citing papers authored by Jiesi Luo

Since Specialization
Citations

This map shows the geographic impact of Jiesi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiesi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiesi Luo more than expected).

Fields of papers citing papers by Jiesi Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiesi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiesi Luo. The network helps show where Jiesi Luo may publish in the future.

Co-authorship network of co-authors of Jiesi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jiesi Luo. A scholar is included among the top collaborators of Jiesi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiesi Luo. Jiesi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Shuang, Xinyue Mei, Qi Xiao, et al.. (2025). Regulating mitochondrial oxidative phosphorylation and MAPK signaling: wedelolactone as a novel therapeutic for radiation-induced thrombocytopenia. Frontiers in Pharmacology. 16. 1508215–1508215. 1 indexed citations
2.
Liang, Cong, et al.. (2024). miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers. Technology in Cancer Research & Treatment. 23. 2233990464–2233990464. 1 indexed citations
3.
Ellis, Matthew W., Yan Huang, Christopher W. Anderson, et al.. (2024). De Novo Elastin Assembly Alleviates Development of Supravalvular Aortic Stenosis—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 44(7). 1674–1682. 1 indexed citations
4.
Luo, Jiesi, et al.. (2024). Unveiling diagnostic information for type 2 diabetes through interpretable machine learning. Information Sciences. 690. 121582–121582. 1 indexed citations
5.
He, Siyu, Sheng Liu, Xinyue Mei, et al.. (2024). A novel therapeutic strategy for leukopenia: Miltefosine activates the Ras/MEK/ERK pathway to promote neutrophil differentiation. Biochemical and Biophysical Research Communications. 746. 151239–151239. 1 indexed citations
6.
Ji, Junyi, et al.. (2023). Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges. Tissue Engineering Part B Reviews. 29(4). 441–455. 5 indexed citations
7.
Lv, Yuebin, Chen Mao, Xiang Gao, et al.. (2022). The obesity paradox is mostly driven by decreased noncardiovascular disease mortality in the oldest old in China: a 20-year prospective cohort study. Nature Aging. 2(5). 389–396. 57 indexed citations
8.
Wang, Juan, Mehmet H. Kural, Jonathan Wu, et al.. (2021). An ex vivo physiologic and hyperplastic vessel culture model to study intra-arterial stent therapies. Biomaterials. 275. 120911–120911. 14 indexed citations
9.
Tang, Wenyan, Yanhua Zhang, Yao Liao, et al.. (2021). Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice. Immunology Letters. 231. 49–60. 6 indexed citations
10.
Zhou, J H, Yuebin Lv, Chen Mao, et al.. (2020). Development and Validation of a Nomogram for Predicting the 6-Year Risk of Cognitive Impairment Among Chinese Older Adults. Journal of the American Medical Directors Association. 21(6). 864–871.e6. 26 indexed citations
11.
Cong, Xiaoqiang, Shang‐Min Zhang, Matthew W. Ellis, & Jiesi Luo. (2019). Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells. Stem Cells and Development. 28(19). 1288–1298. 14 indexed citations
12.
Cong, Xiaoqiang, et al.. (2019). Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts. Stem Cells and Development. 28(24). 1581–1594. 12 indexed citations
13.
Park, Jin‐Kyu, Christopher W. Anderson, Lorenzo R. Sewanan, et al.. (2019). Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes. Acta Biomaterialia. 102. 220–230. 24 indexed citations
14.
Li, Tiantian, Yi Zhang, Jiaonan Wang, et al.. (2018). All-cause mortality risk associated with long-term exposure to ambient PM2·5 in China: a cohort study. The Lancet Public Health. 3(10). e470–e477. 224 indexed citations
15.
Luo, Jiesi, et al.. (2017). [Relationship between the successful aging and survival status among the elderly from longevity areas in China].. PubMed. 51(11). 1024–1027. 2 indexed citations
16.
Luo, Jiesi & José B. Cibelli. (2016). Conserved Role of bFGF and a Divergent Role of LIF for Pluripotency Maintenance and Survival in Canine Pluripotent Stem Cells. Stem Cells and Development. 25(21). 1670–1680. 12 indexed citations
17.
Xie, Gaoqiang, et al.. (2016). OS 17-01 RELATIONSHIP OF BASELINE BLOOD PRESSURE WITH 10 YEARS PROGRESSION OF CAROTID ATHEROSCLEROSIS. Journal of Hypertension. 34(Supplement 1). e221–e221. 1 indexed citations
18.
Yin, Zhaoxue, et al.. (2015). [Association between anemia and 3-year all-cause mortality among oldest old people in longevity areas in China].. PubMed. 36(7). 682–6. 2 indexed citations
19.
Yin, Zhaoxue, Jing Wu, Jiesi Luo, et al.. (2015). Burden and trend analysis of injury mortality in China among children aged 0–14 years from 2004 to 2011. BMJ Open. 5(7). e007307–e007307. 28 indexed citations
20.
Luo, Jiesi, Steven T. Suhr, Elizabeth Chang, et al.. (2011). Generation of Leukemia Inhibitory Factor and Basic Fibroblast Growth Factor-Dependent Induced Pluripotent Stem Cells from Canine Adult Somatic Cells. Stem Cells and Development. 20(10). 1669–1678. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinxi Wang Breakdown of academic impact, for papers by Guihua Liu Breakdown of academic impact, for papers by Manabu Akahane Breakdown of academic impact, for papers by Amanda J. LeBlanc Breakdown of academic impact, for papers by Maelene L. Wong Breakdown of academic impact, for papers by Masayuki Kubo Breakdown of academic impact, for papers by Manuel González Breakdown of academic impact, for papers by H. Wayne Sampson Breakdown of academic impact, for papers by Stephen R. Kearns Breakdown of academic impact, for papers by Loren E. Wold
Rankless by CCL
2026